Floatz logo

FILGRASTIM

Autologous Hematopoietic Stem Cell Transplantation

Nanfang Hospital, Southern Medical Universityprotein_peptidePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Autologous Hematopoietic Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
CARVEDILOL
Hospital Clinic of Barcelona
Phase 3BB
Idarubicine
Nanfang Hospital, Southern Medical University
Phase 2/3B
Busulphan
Nanfang Hospital, Southern Medical University
Phase 2/3B
Cyclophosphamide
Nanfang Hospital, Southern Medical University
Phase 2/3B
Enalapril
Hospital Clinic of Barcelona
Phase 3B

View all 10 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →